The DOI matches its OpenAlex record; 253 of the 253 references it cites were found in a registry or an index.
Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,209
Disease control priorities in developing countries
(2006) · Choice Reviews Online · doi:10.5860/choice.44-0343 · Cited by 3,628
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
Opioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637
Addiction and the brain: The neurobiology of compulsion and its persistence
Hyman, S. E., & Malenka, R. C. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094560 · Cited by 1,302
Atkins, D., Eccles, M., Flottorp, S., Guyatt, G. H., Henry, D., Hill, S., Liberati, A., O'Connell, D., Oxman, A. D., Phillips, B., et al. (2004) · BMC Health Services Research · doi:10.1186/1472-6963-4-38 · Cited by 1,235
Lumeij, J. T. (1997) · Clinical Biochemistry of Domestic Animals · doi:10.1016/b978-012396305-5/50031-2 · Cited by 1,163
The Clinical Opiate Withdrawal Scale (COWS)
Wesson, D. R., & Ling, W. (2003) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2003.10400007 · Cited by 1,120
The Effects of Psychosocial Services in Substance Abuse Treatment
McLellan, A. T. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500150065028 · Cited by 869
A 33-Year Follow-up of Narcotics Addicts
Hser, Y.-I., Hoffman, V., Grella, C. E., & Anglin, M. D. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.503 · Cited by 848
Cellular and Synaptic Adaptations Mediating Opioid Dependence
Williams, J. T., Christie, M. J., & Manzoni, O. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.299 · Cited by 848
(2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511722240 · Cited by 648
Drug addiction: the neurobiology of behaviour gone awry
Volkow, N. D., & Li, T.-K. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1539 · Cited by 625
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Eap, C. B., Buclin, T., & Baumann, P. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241140-00003 · Cited by 599
Two New Rating Scales for Opiate Withdrawal
Handelsman, L., Cochrane, K. J., Aronson, M. J., Ness, R., Rubinstein, K. J., & Kanof, P. D. (1987) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952998709001515 · Cited by 599
A Controlled Trial of Buprenorphine Treatment for Opioid Dependence
Johnson, R. E. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480200058024 · Cited by 572
Metzger, D. S., WOODY, G. E., McLellan, A. T., O’Brien, C. P., Druley, P., Navaline, H. A., DePhilippis, D., Stolley, P. D., & Abrutyn, E. (1993) · PubMed · Cited by 530
Pharmacology and Therapeutics.
(1886) · The Lancet · doi:10.1016/s0140-6736(02)13327-7 · Cited by 527
Trends in Abuse of OxyContin® and Other Opioid Analgesics in the United States: 2002-2004
Cicero, T. J., Inciardi, J. A., & Muñoz, A. (2005) · The Journal of Pain · doi:10.1016/j.jpain.2005.05.004 · Cited by 461
Opioid dependence and addiction during opioid treatment of chronic pain
Ballantyne, J. C., & LaForge, S. K. (2007) · Pain · doi:10.1016/j.pain.2007.03.028 · Cited by 447
European journal of gastroenterology and hepatology
Wingate, D. (1990) · Gut · doi:10.1136/gut.31.5.586-a · Cited by 433
Oral naltrexone maintenance treatment for opioid dependence
Minozzi, S., Amato, L., Vecchi, S., Davoli, M., Kirchmayer, U., & Verster, A. D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001333.pub4 · Cited by 419
Methadone maintenance at different dosages for opioid dependence
Faggiano, F., Vigna-Taglianti, F., Versino, E., & Lemma, P. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002208 · Cited by 406
A Medical Treatment for Diacetylmorphine (Heroin) Addiction
Dole, V. P., & Nyswander, M. (1966) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-196604000-00028 · Cited by 404
Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial
Ling, W., Charuvastra, C., Collins, J. F., Batki, S., Brown, L. S., Kintaudi, P., Wesson, D. R., Mcnicholas, L., Tusel, D. J., Malkerneker, U., et al. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.9344753.x · Cited by 402
Amato, L., Minozzi, S., Davoli, M., & Vecchi, S. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004147.pub4 · Cited by 370
Integrating Primary Medical Care With Addiction Treatment: A Randomized Controlled Trial
Weisner, C., Mertens, J., Parthasarathy, S., Moore, C., & Lu, Y. (2001) · JAMA · doi:10.1001/jama.286.14.1715 · Cited by 368
A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence
Ling, W. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050035005 · Cited by 366
Counseling plus Buprenorphine–Naloxone Maintenance Therapy for Opioid Dependence
Fiellin, D. A., Pantalon, M. V., Chawarski, M. C., Moore, B. A., Sullivan, L. E., O'Connor, P. G., & Schottenfeld, R. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055255 · Cited by 351
Comer, S. D., Sullivan, M. A., Yu, E., Rothenberg, J. L., Kleber, H. D., Kampman, K., Dackis, C., & O’Brien, C. P. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.210 · Cited by 348
Lucas, G. M., Gebo, K. A., Chaisson, R. E., & Moore, R. D. (2002) · AIDS · doi:10.1097/00002030-200203290-00012 · Cited by 320
Comparison of buprenorphine and methadone in the treatment of opioid dependence
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.7.1025 · Cited by 305
Suicide among heroin users: rates, risk factors and methods
Darke, S., & Ross, J. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00214.x · Cited by 304
Buprenorphine vs Methadone Maintenance Treatment for Concurrent Opioid Dependence and Cocaine Abuse
Schottenfeld, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830200041006 · Cited by 303
Neuroscience of Psychoactive Substance Use and Dependence
MANN, K. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00906.x · Cited by 298
Buprenorphine for the management of opioid withdrawal
Gowing, L., Ali, R., & White, J. M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002025.pub4 · Cited by 297
Health in Prisons: A WHO Guide to the Essentials in Prison Health
Møller, L., & Inrichtingen, N. M. V. J. D. J. (2007) · Medical Entomology and Zoology · Cited by 296
Increased probability of GABA release during withdrawal from morphine
Bonci, A., & Williams, J. T. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-02-00796.1997 · Cited by 286
Mattick, R. P., Ali, R., White, J. M., O'Brien, S., Wolk, S., & Danz, C. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00335.x · Cited by 285
Acute administration of buprenorphine in humans: partial agonist and blockade effects.
Walsh, S. L., Preston, K. L., Bigelow, G. E., & Stitzer, M. L. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10510-7 · Cited by 283
The economic costs of heroin addiction in the United States
Mark, T. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00162-9 · Cited by 271
Alpha2-adrenergic agonists for the management of opioid withdrawal
Gowing, L., Farrell, M., Ali, R., & White, J. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002024.pub5 · Cited by 271
Buprenorphine versus Methadone Maintenance for Opioid Dependence
KOSTEN, T. R., SCHOTTENFELD, R., ZIEDONIS, D., & FALCIONI, J. (1993) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199306000-00004 · Cited by 267
The quantification of mortality resulting from the regular use of illicit opiates
Hulse, G. K., English, D. R., Milne, E., & Holman, C. D. J. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.9422216.x · Cited by 258
CRETTOL, S., DEGLON, J., BESSON, J., CROQUETTEKROKAR, M., HAMMIG, R., GOTHUEY, I., MONNAT, M., & EAP, C. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.09.012 · Cited by 250
Seal, K. H. (2005) · Journal of Urban Health: Bulletin of the New York Academy of Medicine · doi:10.1093/jurban/jti053 · Cited by 244
French Field Experience with Buprenorphine
Auriacombe, M., Fatséas, M., Dubernet, J., Daulouède, J., & Tignol, J. (2004) · The American Journal on Addictions · doi:10.1080/10550490490440780 · Cited by 240
KHARASCH, E., HOFFER, C., WHITTINGTON, D., & SHEFFELS, P. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.05.003 · Cited by 238
Deaths involving buprenorphine: a compendium of French cases
Kintz, P. (2001) · Forensic Science International · doi:10.1016/s0379-0738(01)00454-6 · Cited by 233
Ling, W., Amass, L., Shoptaw, S., Annon, J. J., Hillhouse, M., Babcock, D., Brigham, G., Harrer, J., Reid, M., Muir, J., et al. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01154.x · Cited by 233
Brugal, M. T., Domingo‐Salvany, A., Puig, R., Barrio, G., García de Olalla, P., & De La Fuente, L. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01089.x · Cited by 228
Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment
CRETTOL, S., DEGLON, J., BESSON, J., CROQUETTEKROKKAR, M., GOTHUEY, I., HAMMIG, R., MONNAT, M., HUTTEMANN, H., BAUMANN, P., & EAP, C. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.08.011 · Cited by 228
ROSS, J., TEESSON, M., DARKE, S., LYNSKEY, M., ALI, R., RITTER, A., & COOKE, R. (2005) · Drug and Alcohol Review · doi:10.1080/09595230500286039 · Cited by 226
Dose-Response Effects of Methadone in the Treatment of Opioid Dependence
Strain, E. C., Stitzer, M. L., Liebson, I. A., & Bigelow, G. E. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-1-199307010-00004 · Cited by 224
Methadone at tapered doses for the management of opioid withdrawal
Amato, L., Davoli, M., Minozzi, S., Ferroni, E., Ali, R., & Ferri, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003409.pub4 · Cited by 222
Amato, L., Minozzi, S., Davoli, M., & Vecchi, S. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005031.pub4 · Cited by 221
Davoli, M., Bargagli, A. M., Perucci, C. A., Schifano, P., Belleudi, V., Hickman, M., Salamina, G., Diecidue, R., Vigna‐Taglianti, F., Faggiano, F., et al. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.02025.x · Cited by 220
Contingent take-home incentive: Effects on drug use of methadone maintenance patients.
Stitzer, M. L., Iguchi, M. Y., & Felch, L. J. (1992) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.60.6.927 · Cited by 217
Silverman, K., Svikis, D., Robles, E., Stitzer, M. L., & Bigelow, G. E. (2001) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.9.1.14 · Cited by 217
Newman, R., & Whitehill, W. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91550-2 · Cited by 216
Naltrexone pharmacotherapy for opioid dependent federal probationers
Cornish, J. W., Metzger, D., Woody, G. E., Wilson, D., McLellan, A. T., Vandergrift, B., & O'Brien, C. P. (1997) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(97)00020-2 · Cited by 215
Methadone Treatment of Randomly Selected Criminal Addicts
Dole, V. P., Robinson, J. W., Orraca, J., Towns, E., Searcy, P., & Caine, E. (1969) · New England Journal of Medicine · doi:10.1056/nejm196906192802502 · Cited by 215
Opioid Tolerance and Hyperalgesia
Chang, G., Chen, L., & Mao, J. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2006.10.003 · Cited by 211
Ling, W. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770060043007 · Cited by 211
Lugo, R. A., Satterfield, K. L., & Kern, S. E. (2005) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/j354v19n04_05 · Cited by 208
Psychotherapy in community methadone programs: a validation study
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.9.1302 · Cited by 205
Marsch, L. A., Bickel, W. K., Badger, G. J., Stothart, M. E., Quesnel, K. J., Stanger, C., & Brooklyn, J. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.10.1157 · Cited by 205
Substitution treatment of injecting opioid users for prevention of HIV infection
Gowing, L., Farrell, M., Bornemann, R., & Ali, R. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004145.pub2 · Cited by 204
Dolan, K. A., Shearer, J., MacDonald, M., Mattick, R. P., Hall, W., & Wodak, A. D. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00187-x · Cited by 203
Effects of adding behavioral treatment to opioid detoxification with buprenorphine.
Bickel, W. K., Amass, L., Higgins, S. T., Badger, G. J., & Esch, R. A. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.65.5.803 · Cited by 199
Carroll, K. M., Ball, S. A., Nich, C., O'Connor, P. G., Eagan, D. A., Frankforter, T. L., Triffleman, E. G., Shi, J., & Rounsaville, B. J. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.8.755 · Cited by 197
Retention in methadone maintenance and heroin addicts’risk of death
CAPLEHORN, J. R. M., DALTON, M. S. Y. N., CLUFF, M. C., & PETRENAS, A. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb00879.x · Cited by 196
Overcoming Barriers to Prevention, Care, and Treatment of Hepatitis C in Illicit Drug Users
Edlin, B. R., Kresina, T. F., Raymond, D. B., Carden, M. R., Gourevitch, M. N., Rich, J. D., Cheever, L. W., & Cargill, V. A. (2005) · Clinical Infectious Diseases · doi:10.1086/427441 · Cited by 192
Opioid Tolerance–In Search of the Holy Grail
Kieffer, B. L., & Evans, C. J. (2002) · Cell · doi:10.1016/s0092-8674(02)00666-9 · Cited by 191
Deaths Attributable to Methadone vs Buprenorphine in France
Auriacombe, M. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.1.45 · Cited by 191
Pharmacokinetics of the combination tablet of buprenorphine and naloxone
CHIANG, C. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00058-9 · Cited by 186
Abuse liability of buprenorphine–naloxone tablets in untreated IV drug users
Alho, H., Sinclair, D., Vuori, E., & Holopainen, A. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.09.012 · Cited by 185
A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence
Johnson, R. E., Eissenberg, T., Stitzer, M. L., Strain, E. C., Liebson, I. A., & Bigelow, G. E. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01186-2 · Cited by 183
Methadone Maintenance in Primary Care: A Randomized Controlled Trial
Fiellin, D. A., O'Connor, P. G., Chawarski, M., Pakes, J. P., Pantalon, M. V., & Schottenfeld, R. S. (2001) · JAMA · doi:10.1001/jama.286.14.1724 · Cited by 182
The Swedish methadone maintenance program: A controlled study
Gunne, L.-M., & Grönbladh, L. (1981) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(81)90096-x · Cited by 181
Cost-benefit analysis of drug treatment services: review of the literature
Cartwright, W. S. (2000) · The Journal of Mental Health Policy and Economics · doi:10.1002/1099-176x(200003)3:1<11::aid-mhp66>3.0.co;2-0 · Cited by 179
Naloxone treatment in opioid addiction: the risks and benefits
van Dorp, E. L., Yassen, A., & Dahan, A. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.2.125 · Cited by 179
Three Methods of Opioid Detoxification in a Primary Care Setting: A Randomized Trial
O'Connor, P. G., Carroll, K. M., Shi, J. M., Schottenfeld, R. S., Kosten, T. R., & Rounsaville, B. J. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-7-199710010-00004 · Cited by 178
HIV seroconversion in intravenous drug users in San Francisco, 1985–1990
Moss, A. R., Vranizan, K., Gorter, R., Bacchetti, P., Watters, J., & Osmond, D. (1994) · AIDS · doi:10.1097/00002030-199402000-00010 · Cited by 178
Providing medical care to methadone clinic patients: referral vs on-site care.
Umbricht-Schneiter, A., Ginn, D. H., Pabst, K. M., & Bigelow, G. E. (1994) · American Journal of Public Health · doi:10.2105/ajph.84.2.207 · Cited by 176
Depot naltrexone: long-lasting antagonism of the effects of heroin in humans
Comer, S., Collins, E., Kleber, H., Nuwayser, E., Kerrigan, J., & Fischman, M. (2002) · Psychopharmacology · doi:10.1007/s002130100909 · Cited by 175
How many dependent heroin users are there in Australia?
Hall, W. D., Ross, J. E., Lynskey, M. T., Law, M. G., & Degenhardt, L. J. (2000) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2000.tb139321.x · Cited by 172
A Randomized Trial of Integrated Outpatient Treatment for Medically Ill Alcoholic Men
Willenbring, M. L., & Olson, D. H. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.16.1946 · Cited by 172
Buprenorphine: a controlled clinical trial in the treatment of opioid dependence
Pani, P., Maremmani, I., Pirastu, R., Tagliamonte, A., & Gessa, G. L. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00140-4 · Cited by 169
Double-blind randomized trial of buprenorphine and methadone in opiate dependence
Petitjean, S. A., Stohler, R., Déglon, J., Livoti, S., Waldvogel, D., Uehlinger, C., & Ladewig, D. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00163-0 · Cited by 169
Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use.
Hartel, D. M., Schoenbaum, E. E., Selwyn, P. A., Kline, J., Davenny, K., Klein, R. S., & Friedland, G. H. (1995) · American Journal of Public Health · doi:10.2105/ajph.85.1.83 · Cited by 169
Injecting misuse of buprenorphine among French drug users
Obadia, Y., Perrin, V., Feroni, I., Vlahov, D., & Moatti, J. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.96226710.x · Cited by 169
Effects of buprenorphine/naloxone in opioid-dependent humans
Stoller, K. B., Bigelow, G. E., Walsh, S. L., & Strain, E. C. (2001) · Psychopharmacology · doi:10.1007/s002130000637 · Cited by 165
Iguchi, M. Y., Belding, M. A., Morral, A. R., & Lamb, R. J. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.65.3.421 · Cited by 164
Recovery from opioid addiction in DATOS
Flynn, P. M., Joe, G. W., Broome, K. M., Simpson, D. D., & Brown, B. S. (2003) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(03)00125-9 · Cited by 159
Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence
Montoya, I. D., Gorelick, D. A., Preston, K. L., Schroeder, J. R., Umbricht, A., Cheskin, L. J., Lange, W. R., Contoreggi, C., Johnson, R. E., & Fudala, P. J. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.09.004 · Cited by 159
Short-term Interpersonal Psychotherapy in Methadone-Maintained Opiate Addicts
Rounsaville, B. J. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.04390010039005 · Cited by 155
Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up
D, A. G. M., & Herrera, J. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01205-2 · Cited by 151
INVOLVEMENT OF CYP3A4, CYP2C8, AND CYP2D6 IN THE METABOLISM OF (R)- AND (S)-METHADONE IN VITRO
Wang, J.-S., & DeVane, C. L. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.6.742 · Cited by 150
Predicting Long-Term Stable Recovery from Heroin Addiction
Hser, Y. (2007) · Journal of Addictive Diseases · doi:10.1300/j069v26n01_07 · Cited by 148
Fanoe, S., Hvidt, C., Ege, P., & Jensen, G. B. (2007) · Heart · doi:10.1136/hrt.2006.100180 · Cited by 147
Preston, K. L., Umbricht, A., & Epstein, D. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.4.395 · Cited by 146
The cost‐effectiveness of methadone maintenance as a health care intervention
Barnett, P. G. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.9444793.x · Cited by 142
Mortality associated with New South Wales methadone programs in 1994: lives lost and saved
Caplehorn, J. R. M., & Drummer, O. H. (1999) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb127675.x · Cited by 141
Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?
Jenkinson, R., Clark, N. C., FRY, C. L., & Dobbin, M. (2005) · Addiction · doi:10.1111/j.1360-0443.2004.00958.x · Cited by 141
Teesson, M., Ross, J., Darke, S., Lynskey, M., Ali, R., Ritter, A., & Cooke, R. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.11.009 · Cited by 141
Immunotherapy for the treatment of drug abuse
Kosten, T., & Owens, S. M. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.009 · Cited by 135
Amass, L., Kamien, J. B., & Mikulich, S. K. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00074-5 · Cited by 135
Harris, D. S., Jones, R. T., Welm, S., Upton, R. A., Lin, E. T., & Mendelson, J. E. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00126-5 · Cited by 132
Nelson-Zlupko, L., Dore, M. M., Kauffman, E., & Kaltenbach, K. A. (1996) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(95)02061-6 · Cited by 131
Clonidine in Outpatient Detoxification From Methadone Maintenance
Kleber, H. D. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790270081009 · Cited by 127
A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids
Cheskin, L. J., Fudala, P. J., & Johnson, R. E. (1994) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(94)90093-0 · Cited by 121
Collins, E. D., Kleber, H. D., Whittington, R. A., & Heitler, N. E. (2005) · JAMA · doi:10.1001/jama.294.8.903 · Cited by 119
Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts
Fudala, P. J., Yu, E., Macfadden, W., Boardman, C., & Chiang, C. N. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00008-8 · Cited by 119
Schottenfeld, R. S., Pakes, J., Ziedonis, D. M., & Kosten, T. R. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90258-f · Cited by 118
Behavioral family counseling and naltrexone for male opioid-dependent patients.
Fals-Stewart, W., & O'Farrell, T. J. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.3.432 · Cited by 116
Methadone dose and heroin use during maintenance treatment
Caplehorn, J. R. M., Bell, J. R., Kleinbaum, D. G., & Gebski, V. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02769.x · Cited by 116
Methadone dose and treatment outcome.
Strain, E., Stitzer, M., Liebson, I., & Bigelow, G. (1993) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(93)90052-r · Cited by 115
McCollister, K. E., & French, M. T. (2003) · Addiction · doi:10.1111/j.1360-0443.2003.00541.x · Cited by 114
Buster, M. C. A., van Brussel, G. H. A., & van den Brink, W. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00179.x · Cited by 113
A new series of 13 buprenorphine-related deaths
Kintz, P. (2002) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00304-1 · Cited by 112
Vidal-Trecan, G. M. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00312-5 · Cited by 111
Comparison of methadone and slow‐release morphine maintenance in pregnant addicts
Fischer, G., Jagsch, R., Eder, H., Gombas, W., Etzersdorfer, P., Schmidl-Mohl, K., Schatten, C., Weninger, M., & Aschauer, H. N. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.9422317.x · Cited by 109
Patterns of symptom complaints in methadone maintenance patients
Dyer, K. R., & White, J. M. (1997) · Addiction · doi:10.1046/j.1360-0443.1997.921114456.x · Cited by 109
Avants, S. K., Margolin, A., Sindelar, J. L., Rounsaville, B. J., Schottenfeld, R., Stine, S., Cooney, N. L., Rosenheck, R. A., Li, S.-H., & Kosten, T. R. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.1.27 · Cited by 108
Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users
Strain, E. C., Stitzer, M. L., Liebson, I. A., & Bigelow, G. E. (1994) · Psychopharmacology · doi:10.1007/bf02247469 · Cited by 108
Treating Homeless Opioid Dependent Patients with Buprenorphine in an Office-Based Setting
Alford, D. P., LaBelle, C. T., Richardson, J. M., O’Connell, J. J., Hohl, C., Cheng, D. M., & Samet, J. H. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0023-1 · Cited by 107
Eder, H., Jagsch, R., Kraigher, D., Primorac, A., Ebner, N., & Fischer, G. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.001128.x · Cited by 107
Torsades de PointesAssociated with High Dose Levomethadyl Acetate (ORLAAM®)
Deamer, R. L., Wilson, D. R., Clark, D., & Prichard, J. G. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v20n04_02 · Cited by 105
A novel bivalent morphine/heroin vaccine that prevents relapse to heroin addiction in rodents
Antón, B., & Leff, P. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.01.047 · Cited by 104
Molecular mechanisms of drug addiction: adaptations in signal transduction pathways.
Nestler, E. J., Berhow, M. T., & Brodkin, E. S. (1996) · PubMed · Cited by 103
Does post‐withdrawal cue exposure improve outcome in opiate addiction? A controlled trial
Dawe, S., Powell, J. E., Richards, D. A., Gossop, M., Marks, I. M., Strang, J., & Gray, J. A. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02146.x · Cited by 103
Multiple opioid receptor systems in brain and spinal cord: Part 2.
Yaksh, T. L. (1984) · PubMed · Cited by 102
LAAM maintenance vs methadone maintenance for heroin dependence
Clark, N. C., Lintzeris, N., Gijsbers, A. J., Whelan, G., Dunlop, A. J., Ritter, A. J., & Ling, W. W. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002210 · Cited by 102
International response to the HIV/AIDS epidemic: planning for success.
Piot, P. K., & Seck, A. (2001) · PubMed · Cited by 102
Lintzeris, N., Bell, J. R., Bammer, G., Jolley, D. J., & Rushworth, R. L. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00215.x · Cited by 102
Comer, S. D., & Collins, E. D. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.038141 · Cited by 101
Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers
Strain, E. C., Stoller, K. B., WALSH, S. L., & Bigelow, G. E. (2000) · Psychopharmacology · doi:10.1007/s002130050066 · Cited by 100
Comer, S. D., Walker, E. A., & Collins, E. D. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0023-6 · Cited by 98
Mortality among problem drug users in Rome: an 18‐year follow‐up study, 1980–97
Bargagli, A. M., Sperati, A., Davoli, M., Forastiere, F., & Perucci, C. A. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.961014559.x · Cited by 97
Endogenous opiates and behavior: 2005
Bodnar, R. J., & Klein, G. E. (2006) · Peptides · doi:10.1016/j.peptides.2006.07.011 · Cited by 96
Bearn, J., Gossop, M., & Strang, J. (1996) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(96)01289-6 · Cited by 95
The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington, New Zealand
Robinson, G. (1993) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(93)90036-p · Cited by 94
Gourevitch, M. N., Selwyn, P. A., Davenny, K., Buono, D., Schoenbaum, E. E., Klein, R. S., & Friedland, G. H. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-5-199303010-00005 · Cited by 93
Adherence to hepatitis C treatment in recovering heroin users maintained on methadone
Sylvestre, D. L., & Clements, B. J. (2007) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3281bcb8d8 · Cited by 93
WINSTOCK, A. R., Lea, T., & Sheridan, J. L. (2008) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2007.03.002 · Cited by 92
Community Reinforcement Approach in the Treatment of Opiate Addicts
Abbott, P. J., Weller, S. B., Delaney, H. D., & Moore, B. A. (1998) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999809001696 · Cited by 91
Clonidine and opiate receptor antagonists in the treatment of heroin addiction
Gerra, G., Marcato, A., Caccavari, R., Fontanesi, B., Delsignore, R., Affini, G. F., Avanzini, P., Rustichelli, P., & Passeri, M. (1995) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(94)00077-8 · Cited by 90
Buprenorphine in opiate withdrawal: A comparison with clonidine
NIGAM, A. K., Ray, R., & Tripathi, B. M. (1993) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(93)90024-v · Cited by 90
The natural history of adolescent drug use
Robins, L. N. (1984) · American Journal of Public Health · doi:10.2105/ajph.74.7.656 · Cited by 88
Methadone treatment and hiv and hepatitis band C risk reduction among injectiors in the seattle area
Thiede, H., Hagan, H., & Murrill, C. S. (2000) · Journal of Urban Health · doi:10.1007/bf02386744 · Cited by 87
Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin
Sullivan, M. A., Vosburg, S. K., & Comer, S. D. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0509-x · Cited by 87
The efficacy of naltrexone in preventing reabuse of heroin after detoxification
Shufman, E., Porat, S., Witztum, E., Gandacu, D., Bar‐Hamburger, R., & Ginath, Y. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91240-8 · Cited by 84
Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal
Gowing, L., Ali, R. L., & White, J. M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002022.pub3 · Cited by 84
Psychotherapy for opiate addicts.
Ge, W., Luborsky, L. B., McLellan, A. T., Cp, O., At, B., Blaine, J., Herman, I., & Hole, A. V. (1983) · PubMed · Cited by 84
FOSTER, J., Brewer, C. L., & STEELE, T. (2003) · Addiction Biology · doi:10.1080/1355621031000117446 · Cited by 83
Adherence to Hepatitis B Virus Vaccination At Syringe Exchange Sites
Altice, F. L., Bruce, R. D., Walton, M. R., & Buitrago, M. I. (2005) · Journal of Urban Health · doi:10.1093/jurban/jti016 · Cited by 83
Hser, Y., Anglin, M., & Fletcher, B. W. (1998) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(97)00308-5 · Cited by 82
D’Ippoliti, D., Davoli, M., Perucci, C. A., Pasqualini, F., & Bargagli, A. M. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00091-x · Cited by 82
Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans
Comer, S. D., Collins, E. D., & Fischman, M. W. (2001) · Psychopharmacology · doi:10.1007/s002130000623 · Cited by 80
Hulse, G. K., Tait, R. J., Comer, S. D., Sullivan, M. A., Jacobs, I. G., & Arnold-Reed, D. E. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.02.009 · Cited by 80
Piper, T. M., Rudenstine, S., Stancliff, S., Sherman, S. G., Nandi, V., Clear, A., & Galea, S. (2007) · Harm Reduction Journal · doi:10.1186/1477-7517-4-3 · Cited by 79
Human immunodeficiency virus infection in intravenous drug users: A model for primary care
O’Connor, P. G., Molde, S., Henry, S., et al. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90166-9 · Cited by 79
Buprenorphine and naloxone interactions in opiate-dependent volunteers*
Mendelson, J. E., Jones, R. T., Fernandez, I., Welm, S., Melby, A. K., & Baggott, M. J. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90173-3 · Cited by 79
Amass, L., Kamien, J. B., & Mikulich, S. K. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00141-1 · Cited by 79
Opioid antagonists with minimal sedation for opioid withdrawal
Gowing, L., Ali, R. L., & White, J. M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002021.pub4 · Cited by 78
Follow‐up after a six‐month maintenance period on naltrexone versus placebo in heroin addicts
SAN, L., POMAROL, G., Peri, J., OLLE, J. M., & Camı́, J. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01859.x · Cited by 78
Primary care-based ambulatory opioid detoxification
O’Connor, P. G., Waugh, M. E., Carroll, K. M., Rounsaville, B. J., Diagkogiannis, I. A., & Schottenfeld, R. S. (1995) · Journal of General Internal Medicine · doi:10.1007/bf02599882 · Cited by 78
Self-Reported Adherence to Antiretroviral Treatment among HIV-Infected People in Central China
Wang, H., He, G., Li, X., Ai-yun, Y., Chen, X., Fennie, K., & Williams, A. B. (2007) · AIDS Patient Care and STDs · doi:10.1089/apc.2007.0047 · Cited by 77
Optimizing Response to Methadone Maintenance Treatment: Use of Higher-Dose Methadone
Maxwell, S., & Shinderman, M. S. (1999) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1999.10471730 · Cited by 76
Benefits and costs of methadone treatment: results from a lifetime simulation model
Zarkin, G. A., Dunlap, L. J., Hicks, K. A., & Mamo, D. (2005) · Health Economics · doi:10.1002/hec.999 · Cited by 76
Janiri, L., Mannelli, P., Persico, A. M., Serretti, A., & Tempesta, E. (1994) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(94)90096-5 · Cited by 75
Sustained-release naltrexone: novel treatment for opioid dependence
Comer, S. D., Sullivan, M. A., & Hulse, G. K. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.8.1285 · Cited by 75
Mitchell, T. B., White, J. M., Somogyi, A. A., & Bochner, F. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00764.x · Cited by 75
The functioning and well being of persons who seek treatment for drug and alcohol use
Stein, M. D., Mulvey, K. P., Plough, A. L., & Samet, J. H. (1998) · Journal of Substance Abuse · doi:10.1016/s0899-3289(99)80142-4 · Cited by 74
A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial.
Caplehorn, J. R. M. (2003) · PubMed · doi:10.5694/j.1326-5377.2003.tb05417.x · Cited by 74
International Classification of Diseases 10th edition (ICD-10)
Tzitzivacos, D. (2007) · CME/Continuing medical education · Cited by 73
Soyka, M., Hock, B., Kagerer, S., Lehnert, R., Limmer, C., & Küfner, H. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000178417.60426.60 · Cited by 72
Effect of Buprenorphine and Antiretroviral Agents on the QT Interval in Opioid-Dependent Patients
Baker, J. R., Best, A. M., Pade, P., & McCance‐Katz, E. F. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g524 · Cited by 71
van Ameijden, E. J. C., Langendam, M. W., & Coutinho, R. A. (1999) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00083-5 · Cited by 71
Berger, E. L. (2008) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e31818ec5a0 · Cited by 70
Complications of Ultrarapid Opioid Detoxification with Subcutaneous Naltrexone Pellets
Hamilton, R. J., Olmedo, R., Shah, S. J., Hung, O. L., Howland, M. A., Perrone, J., Nelson, L. S., Lewin, N., & Hoffman, R. S. (2002) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2002.tb01169.x · Cited by 68
Krantz, M. J., Garcia, J. A., & Mehler, P. S. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.25.4.611.61020 · Cited by 68
Voucher-based reinforcement of opiate abstinence during methadone detoxification
Robles, E., Stitzer, M. L., Strain, E. C., Bigelow, G. E., & Silverman, K. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00160-0 · Cited by 67
Mortality risk among new onset injection drug users
Vlahov, D., Wang, C.-L., Galai, N., Bareta, J., Mehta, S. H., Strathdee, S. A., & Nelson, K. E. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00780.x · Cited by 67
Gruber, K. F., Chutuape, M. A., & Stitzer, M. L. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00054-x · Cited by 66
Take-home methadone: Contingency effects on drug-seeking and productivity of narcotic addicts
Milby, J. B., Garrett, C., English, C., Fritschi, O., & Clarke, C. (1978) · Addictive Behaviors · doi:10.1016/0306-4603(78)90022-9 · Cited by 66
The costs of drug abuse consequences: A summary of research findings
French, M. T., & Martin, R. F. (1996) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(96)00128-6 · Cited by 66
Gandhi, D. H., Jaffe, J. H., McNary, S. W., Kavanagh, G. J., Hayes, M., & Currens, M. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00334.x · Cited by 65
Darke, S. G., Ross, J. E., Mills, K. L., Williamson, A., Havard, A., & Teesson, M. (2007) · Addictive Behaviors · doi:10.1016/j.addbeh.2007.01.014 · Cited by 65
Kim, S., Wagner, H. N., Vl, V., Pf, K., Dannals, R. F., Ravert, H. T., Joh, T. H., Rb, D., & Ac, C. (1997) · PubMed · Cited by 65
Methadone Maintenance and Recovery from Opioid Dependence
Maddux, J. F., & Desmond, D. P. (1992) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999209001612 · Cited by 64
Heroin maintenance for chronic heroin dependents
Ferri, M., Davoli, M., & Perucci, C. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003410 · Cited by 63
Vanichseni, S., Wongsuwan, B., Choopanya, K., & Wongpanich, K. (1991) · International Journal of the Addictions · doi:10.3109/10826089109062163 · Cited by 62
Mitchell, T. B., White, J. M., Somogyi, A. A., & Bochner, F. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00190-x · Cited by 61
Effects of buprenorphine sublingual tablet maintenance on opioid drug-seeking behavior by humans
Greenwald, M. K., Schuh, K. J., Hopper, J. A., Schuster, C. R., & Johanson, C. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0975-0 · Cited by 59
The Use of Buprenorphine and Temazepam by Drug Injectors
Lavelle, T. L., Hammersley, R., FORSYTH, A. J. M., & Bain, D. A. (1991) · Journal of Addictive Diseases · doi:10.1300/j069v10n03_02 · Cited by 59
Cited by
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
D’Onofrio, G., O’Connor, P. G., Pantalon, M. V., Chawarski, M. C., Busch, S. H., Owens, P. H., Bernstein, S. L., & Fiellin, D. A. (2015) · JAMA · doi:10.1001/jama.2015.3474 · Cited by 910
Global patterns of opioid use and dependence: harms to populations, interventions, and future action
Degenhardt, L., Grebely, J., Stone, J., Hickman, M., Vickerman, P., Marshall, B. D. L., Bruneau, J., Altice, F. L., Henderson, G., Rahimi-Movaghar, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32229-9 · Cited by 832
Degenhardt, L., Mathers, B., Vickerman, P., Rhodes, T., Latkin, C., & Hickman, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60742-8 · Cited by 423
Management of opioid use disorders: a national clinical practice guideline
Bruneau, J., Ahamad, K., Goyer, M.-È., Poulin, G., Selby, P., Fischer, B., Wild, T. C., & Wood, E. (2018) · Canadian Medical Association Journal · doi:10.1503/cmaj.170958 · Cited by 412
Metadata
- Authors
- Uchtenhagen, A.
- Venue
- Zurich Open Repository and Archive (University of Zurich)
- Publisher
- University of Zurich
- Published
- 2009-01-01
- OpenAlex
- W2891825027
- Cited by
- 490
- References
- 253
- FWCI
- 27.60
- Type
- book
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.